INTERNATIONAL PATENT: OLEMA PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMBINATION TREATMENTS OF AN ESTROGEN-RECEPTOR ANTAGONIST AND AN AKT INHIBITOR"

GENEVA, April 29 -- OLEMA PHARMACEUTICALS, INC. (780 Brannan StreetSan Francisco, CA 94103) filed a patent application (PCT/US2025/051455) for "COMBINATION TREATMENTS OF AN ESTROGEN-RECEPTOR ANTAGONIST AND AN AKT INHIBITOR" on Oct 17, 2025. With publication no. WO/2026/085432, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MYLES, David, C. (c/o Olema Pharmaceuticals, Inc.780 Brannan StreetSan Francisco, CA 94103), PALANISAMY, Gopinath (c/o Olema Pharmaceuticals, Inc.780 Brannan StreetSan Francisco, CA 94103), BARRATT, Su...